Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines
China-based Brii Biosciences Ltd (HKG: 2137) has announced its intention to acquire the intellectual property...
VBI Vaccines
Brii Biosciences Announces Positive Interim Data for BRII-179 Vaccine in Chronic Hepatitis B
China-based Brii Biosciences Ltd (HKG: 2137) has announced topline cohort-level unblinded Week 36 data from...
Brii Biosciences Expands Collaboration with VBI Vaccines on Hepatitis B Virus Therapies
China-based Brii Biosciences Ltd (HKG: 2137) has announced an expanded license agreement with US firm...